FDA Issues New Guidelines On Clinical Trial Enrichment
The U.S. Food and Drug Administration on Monday released draft guidelines on how drug companies can select certain patient populations for clinical trials, a method known as enrichment that FDA officials...To view the full article, register now.
Already a subscriber? Click here to view full article